John C. Klock, M.D. has served as Chief Executive Officer of the Company since 2014 and as Managing Director, Manager and Founder of the Company since 2011.  Prior to serving in these positions with the Company, Dr. Klock was involved in the start-up of five medical companies, including Co-Founder and President of BioMarin Pharmaceutical, which successfully commercialized five FDA drugs; Scientific Founder and Vice President of Research of Glycomed, now Ligand Pharmaceutical; and founding investor in Ultragenyx Pharmaceutical.  He also personally brought to market a novel cancer treatment, the first rapid AIDS test, comprehensive tests for detecting metabolic diseases in children, and several drugs for treating pediatric genetic conditions. Dr. Klock has authored over 70 peer-reviewed medical and scientific publications, and eight granted patents.


Kenneth G. Hungerford II has served as Lead Manager of the Company since 2014 and Founder of the Company since 2011.  Mr. Hungerford also served as the Company’s Chairman of the Board of Managers from 2011 to 2014.  Mr. Hungerford had been a member of the Board of Directors of TechniScan from 2007 to 2011, and served as Chairman of the Board of TechniScan from 2009 until 2011. Mr. Hungerford is currently Lead Director of ADAC Automotive, Inc., a privately held automotive supplier, and has previously served as its Chairman from January 1986 to December 2015. Mr. Hungerford was a founding director of Edge Industries, a privately held capital equipment manufacturer that provides specialized cutting, metering, and dispensing systems for the urethane industry; Lomak Petroleum, which was merged into Range Resources, a publicly traded oil and gas company engaged in the acquisition and development of gas resources; Applied Image Technology, a development stage software company that provides computer based parts manuals, which was merged into MRO, Inc., a publicly traded software company, that was subsequently acquired by IBM; Brilliance Audiobooks, a publisher of audio books, which was recently acquired by Amazon; and WXMI Broadcasting, an independent, local television station in Grand Rapids, Michigan that became the local FOX network affiliate, and was subsequently sold to COX Broadcasting. Additionally, Mr. Hungerford served on the Board of Trustees of St. Mary's Health Care in Grand Rapids, Michigan, which is a member organization in the Trinity Health Network. Mr. Hungerford received a Bachelor of Business Administration degree from the University of Notre Dame in 1968 and has been registered as a Certified Public Accountant in the State of Michigan since 1970.


David C. Gentile is a Manager of the Company.  As Founder and CEO of GPB Capital, Mr. Gentile is responsible for the management of GPB Capital, including the formulation of strategy and oversight of investment policy and leadership of the Acquisition Committee. Prior to founding GPB Capital, Mr. Gentile spent 25 years at the Corporate Advisory and Accounting practice of Gentile Pismeny & Brengel, LLP (“GP&B”) in New York. During this time, he advised clients on business expansion and growth strategies, cash flow management, mergers and acquisitions, recapitalization, spin-offs and divestiture, corporate turn-around and restructuring. He developed and maintained executive level relationships with many of the firm’s 3,000+ entrepreneurial, corporate executive and high-net-worth clients. During his career at GP&B, Mr. Gentile provided financial and strategic advisory services to various companies with a combined enterprise value over $1B in the private and public markets. He earned his Bachelor of Business Studies in Finance and Accounting from Queens College.


Carl Jandernoa has served as a Manager of the Company since 2012. Mr. Jandernoa is an officer and an owner of 42 North Partners, LLC, a privately held investment company located in Grand Rapids, Michigan which specializes in venture capital and growth capital investments.  He previously served as a Vice President of Bridge Street Capital Partners, LLC, a growth capital private equity firm located in Grand Rapids, Michigan.  Mr. Jandernoa also worked in the Global IT Product Management Department at UBS Financial Services, Inc. and was an auditor at Deliotte & Touche. Mr. Jandernoa graduated with a Bachelor of Science degree in Accounting from Marquette University.


Robert Y. Kessler has served as a Manager of the Company since 2012.  He is a Manager and an owner of Biotex Pharma Investments, LLC, a privately-held investment fund located in New York City, New York, which specializes in pharmaceuticals and medical devices.